FOXN3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.347900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.638170E-01
Normal-vs-Stage2
1.155180E-01
Normal-vs-Stage3
1.838400E-01
Normal-vs-Stage4
9.208400E-01
Stage1-vs-Stage2
8.472400E-01
Stage1-vs-Stage3
1.955430E-01
Stage1-vs-Stage4
1.132440E-01
Stage2-vs-Stage3
7.4024000040751E-08
Stage2-vs-Stage4
4.561700E-02
Stage3-vs-Stage4
9.023900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.586200E-02
Normal-vs-AfricanAmerican
5.949200E-01
Normal-vs-Asian
1.523580E-01
Caucasian-vs-AfricanAmerican
2.475800E-01
Caucasian-vs-Asian
5.465800E-01
AfricanAmerican-vs-Asian
3.177800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.188200E-02
Normal-vs-Female
1.592240E-01
Male-vs-Female
3.332400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.625800E-01
Normal-vs-Age(41-60Yrs)
2.085800E-01
Normal-vs-Age(61-80Yrs)
8.539900E-02
Normal-vs-Age(81-100Yrs)
1.706250E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.383600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.990600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.338200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.901900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.041800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.823000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.579800E-02
Normal-vs-Daily Drinker
3.340400E-03
Normal-vs-Weekly Drinker
2.546200E-01
Normal-vs-Occasional Drinker
1.277780E-01
Normal-vs-Social Drinker
5.327800E-01
Non Drinker-vs-Daily Drinker
4.942400E-01
Non Drinker-vs-Weekly Drinker
1.842420E-01
Non Drinker-vs-Occasional Drinker
2.843600E-01
Non Drinker-vs-Social Drinker
1.618630E-01
Daily Drinker-vs-Weekly Drinker
9.930400E-02
Daily Drinker-vs-Occasional Drinker
8.608300E-02
Daily Drinker-vs-Social Drinker
8.519900E-02
Weekly Drinker-vs-Occasional Drinker
7.328400E-01
Weekly Drinker-vs-Social Drinker
6.618000E-01
Occasional Drinker-vs-Social Drinker
4.594800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.326000E-01
Normal-vs-Grade 2
3.281000E-01
Normal-vs-Grade 3
3.780800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.627800E-01
Grade 1-vs-Grade 3
8.156000E-01
Grade 1-vs-Grade 4
5.326000E-01
Grade 2-vs-Grade 3
2.645600E-01
Grade 2-vs-Grade 4
3.281000E-01
Grade 3-vs-Grade 4
3.780800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.972620E-01
Normal-vs-NonDiabetic
3.431800E-02
Diabetic-vs-NonDiabetic
1.658600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.281400E-01
Normal-vs-NoPancreatitis
5.374200E-02
Pancreatitis-vs-NoPancreatitis
9.293000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.698300E-02
Normal-vs-N1
1.226440E-01
N0-vs-N1
1.489950E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.370000E-02
Normal-vs-TP53-NonMutant
2.140000E-01
TP53-Mutant-vs-TP53-NonMutant
1.262170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
